Cat. No. 1554
Chemical Name: 4-[(1E)-2-(3,5-Dihydroxyphenyl)ethe
Biological ActivityAnti-inflammatory, immunomodulatory and antiproliferative agent. Inhibits p56lck and syk protein tyrosine kinases and inhibits TNF-induced NF-κB activation and gene expression. Synthesis results from conversion of resveratrol (Cat. No. 1418) by cytochrome P450 1B1.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Geahlen and McLaughlin (1989) Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem.Biophys.Res.Commun. 165 241. PMID: 2590224.
Oliver et al (1994) Inhibition of mast cell FceR1-mediated signalling and effector function by the syk-selective inhibitor, piceatannol. J.Biol.Chem. 269 29697. PMID: 7961959.
Ashikawa et al (2002) Piceatannol inhibits TNF-induced NF-kB activation and NF-kB-mediated gene expression through suppression of IkBa kinase and p65 phosphorylation. J.Immunol. 169 6490. PMID: 12444159.
Potter et al (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br.J.Cancer 86 774. PMID: 11875742.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Piceatannol, supplier, Syk, p56lck, kinase, inhibitors, TNF-induced, NF-κB, NF-kappaB, NF-kB, activation, Kinases, Nuclear, Factor, Kappa, B, Cytokine, Signaling, Signalling, Transcription, Factors
Find multiple products by catalog number
New Products in this Area
mSTING agonist; induces antitumor immunological responsesC 87
TNF-α inhibitorJTE 607 dihydrochloride
Cytokine release inhibitor; anti-inflammatoryCRID3 sodium salt
Potent NLRP3 inflammasome inhibitor; inhibits IL-1β production
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.